MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202341028322 A) filed by Pillai Universal Llc, Carson City, U.S.A., on Oct. 18, 2023, for 'phenotype and genotype target-based small molecule inhibitors in cancers.'
Inventor(s) include Dr. Baskaran Pillai; and Dr. M. G. Dinesh.
The application for the patent was published on April 25, under issue no. 17/2025.
According to the abstract released by the Intellectual Property India: "The present invention discloses a Phenotype and genotype target-based small molecule inhibitors in cancers. The novel anti-cancer molecules comprises of structures in accordance with Formula 1. Formula 1 or any derivative thereof, pharmaceutically acceptable salt thereof,...